Showing results (81-90 of 206) with videos related to
Sort By:
Pageof 21
Cancers|July 29, 2023
Enhancing Triage Efficiency and Accuracy in Emergency Rooms for Patients with Metastatic Prostate Cancer: A Retrospective Analysis of Artificial Intelligence-Assisted Triage Using ChatGPT 4.0Georges Gebrael, Kamal Kant Sahu, Beverly Chigarira, et al.European Urology|March 12, 2025
T-cell Engagers in Prostate CancerChadi Hage Chehade, Zeynep Irem Ozay, Micah Ostrowski, et al.Cancers|November 14, 2023
Access to Care and Healthcare Quality Metrics for Patients with Advanced Genitourinary Cancers in Urban versus Rural AreasHaoran Li, Kamal Kant Sahu, Shruti Adidam Kumar, et al.The Oncologist|March 23, 2023
Phase I Trial of Combination Therapy With Avelumab and Cabozantinib in Patients With Newly Diagnosed Metastatic Clear Cell Renal Cell CarcinomaHaoran Li, Kamal Kant Sahu, James Brundage, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 28, 2023
Clinical Activity of Combined Telomerase Vaccination and Pembrolizumab in Advanced Melanoma: Results from a Phase I TrialEspen B Ellingsen, Steven O'Day, Artur Mezheyeuski, et al.Cancer|September 12, 2019
Results of a prospective phase 2 study of pazopanib in patients with surgically unresectable or metastatic chondrosarcomaWarren Chow, Paul Frankel, Chris Ruel, et al.Heliyon|September 19, 2022
A retrospective study to evaluate the efficacy and safety of SARS-CoV-2 vaccine in patients with advanced genitourinary cancersHaoran Li, Kamal Kant Sahu, Shruti Adidam Kumar, et al.Cancers|February 11, 2021
Photodynamic Therapy Using Hippo Pathway Inhibitor Verteporfin: A Potential Dual Mechanistic Approach in Treatment of Soft Tissue SarcomasJeffrey D Rytlewski, Nicholas Scalora, Keith Garcia, et al.Prostate Cancer and Prostatic Diseases|July 14, 2025
Cardiovascular risks in men with prostate cancer: a pragmatic, clinician-oriented review of risk stratification and management strategiesAditya Bhave, Harikrishnan Hyma Kunhiraman, Tarek Nahle, et al.CA: a Cancer Journal for Clinicians|January 10, 2025
A pan-tumor review of the role of poly(adenosine diphosphate ribose) polymerase inhibitorsChadi Hage Chehade, Georges Gebrael, Nicolas Sayegh, et al.Pageof 21